Skip to main navigation Skip to search Skip to main content

Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression

  • Maurizio Pieroni
  • , Maria De Santis
  • , Gaetano Zizzo
  • , Silvia Laura Bosello
  • , Costantino Smaldone
  • , Mara Campioni
  • , Giacomo De Luca
  • , Antonella Laria
  • , Agostino Meduri
  • , Fulvio Bellocci
  • , Lorenzo Bonomo
  • , Filippo Crea
  • , Gianfranco Ferraccioli

Research output: Contribution to journalArticle

Abstract

Scleroderma heart disease is a major risk of death in systemic sclerosis (SSc). Mechanisms underlying myocardial damage are still unclear. We performed an extensive study of SSc patients with recent-onset symptoms for heart disease and examined the efficacy of immunosuppressive therapy.
Original languageEnglish
Pages (from-to)526-535
Number of pages10
JournalSeminars in Arthritis and Rheumatism
Volume43
DOIs
Publication statusPublished - 2013

Keywords

  • ANCA
  • Heart disease
  • Myocarditis
  • Parvovirus B19
  • Systemic sclerosis
  • Treatment

Fingerprint

Dive into the research topics of 'Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression'. Together they form a unique fingerprint.

Cite this